Tag Archives: JOBS Act

JOBS Act: Rule 506 Goes Into Effect Today

DC in Fall

Since Congress passed the Jumpstart our Business Startups (JOBS) Act last spring, there have been 39 IPOs in the biotech industry – and counting!  Today, another provision from the JOBS Act takes effect that will further enhance biotech capital formation. Pursuant to rules mandated by the JOBS Act, companies are now able to use general solicitation to advertise to investors when conducting an offering under Rule 506 of SEC Regulation D.  Rule 506 is a Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: ,

Prosensa’s IPO and the Value of the BIO Investor Forum

Hans Schikan

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Our primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington’s disease. We completed an IPO onto NASDAQ in June of this year. Prior to last year’s BIO Investor Forum in San Francisco, we were still in the very Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

JOBS Act Provides Innovators with Capital Boost

jobs-act-article

Despite all the talk of gridlock and polarization in Washington these days, successful, bipartisan pieces of legislation are not a thing of the past. One of them is the Jumpstart Our Business Startups (JOBS) Act, which makes it easier for emerging growth companies to raise capital by going public. The JOBS Act provides qualifying companies with a five year “on-ramp” period to comply with some of the regulatory requirements involved when making the transition from Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , ,